ALTEOGEN Market Cap

ALTEOGEN has a market cap or net worth of 21.11 trillion as of June 27, 2025. Its market cap has increased by 118.21% in one year.

Market Cap

21.11T

Enterprise Value

20.91T

Revenue

151.65B

Ranking

n/a

PE Ratio

169.44

Stock Price

380,500.00

Market Cap Chart

Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 21.11T, an increase of 17,497.58%. That is a compound annual growth rate of 63.26%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	20.33T	23.28%
Dec 30, 2024	16.49T	221.05%
Dec 28, 2023	5,137.84B	160.78%
Dec 29, 2022	1,970.17B	-38.41%
Dec 30, 2021	3,198.72B	-36.62%
Dec 30, 2020	5,046.50B	442.81%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.10T
Celltrion	35.38T
Yuhan	7,588.59B
SK Biopharmaceuticals	7,196.99B
HLB Co., Ltd.	6,283.13B
PharmaResearch	5,189.63B
Peptron	4,822.55B
LigaChem Biosciences	4,016.73B

Market Cap Rankings